Kaliumchloride Natriumchloride B. Braun (Potassium Chloride, Sodium Chloride)

The formulation delivers potassium and sodium directly into the bloodstream, raising extracellular concentrations of these ions. Increased potassium helps normalize membrane potentials and muscle function, while sodium supports fluid balance and osmotic pressure, together correcting the biochemical disturbances that cause low serum potassium or sodium.

The dose is individualized and determined by the prescribing clinician based on the patient’s electrolyte levels, renal function, and clinical condition. Healthcare professionals calculate the required amount of potassium and sodium to safely correct the specific deficit.

Safety in pregnancy and lactation has not been definitively established. The product should only be used when the potential therapeutic benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Kaliumchloride Natriumchloride B. Braun combines both potassium and sodium in a single sterile injection, offering convenience over separate potassium or sodium preparations. It provides rapid correction of mixed electrolyte deficits, whereas single‑ion solutions address only one electrolyte abnormality.

The product must be stored at 2‑8 °C, protected from light, and should not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

It is administered intravenously by a qualified healthcare professional. The solution is typically diluted in compatible IV fluids and infused over a period determined by the patient’s electrolyte status and clinical response, with continuous monitoring of serum levels.

The most serious risks include severe hyperkalemia or hypernatremia, which can cause cardiac arrhythmias, neurological disturbances, or renal impairment. Anaphylactic reactions and severe local vein inflammation are also possible, requiring immediate medical attention.

Patients with known hypersensitivity to potassium chloride, sodium chloride, or any excipients in the formulation should avoid it. It is also contraindicated in individuals with severe renal failure, uncontrolled hyperkalemia, or uncontrolled hypernatremia unless closely monitored.